-
Something wrong with this record ?
The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs
M. Piskacek, M. Havelka, K. Jendruchova, A. Knight, LP. Keegan,
Language English Country Switzerland
Document type Journal Article
Grant support
15-32935A
Ministerstvo Zdravotnictví Ceské Republiky
NLK
PubMed Central
from 1997
ProQuest Central
from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01 to 1 year ago
- MeSH
- Transcriptional Activation MeSH
- Gene Duplication MeSH
- Phylogeny MeSH
- Introns genetics MeSH
- Humans MeSH
- Evolution, Molecular * MeSH
- Gene Expression Regulation * MeSH
- Amino Acid Sequence MeSH
- Sequence Homology MeSH
- Sp2 Transcription Factor antagonists & inhibitors genetics metabolism MeSH
- Valine genetics metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The universal nine-amino-acid transactivation domains (9aaTADs) have been identified in numerous transcription activators. Here, we identified the conserved 9aaTAD motif in all nine members of the specificity protein (SP) family. Previously, the Sp1 transcription factor has been defined as a glutamine-rich activator. We showed by amino acid substitutions that the glutamine residues are completely dispensable for 9aaTAD function and are not conserved in the SP family. We described the origin and evolutionary history of 9aaTADs. The 9aaTADs of the ancestral Sp2 gene became inactivated in early chordates. We next discovered that an accumulation of valines in 9aaTADs inactivated their transactivation function and enabled their strict conservation during evolution. Subsequently, in chordates, Sp2 has duplicated and created new paralogs, Sp1, Sp3, and Sp4 (the SP1-4 clade). During chordate evolution, the dormancy of the Sp2 activation domain lasted over 100 million years. The dormant but still intact ancestral Sp2 activation domains allowed diversification of the SP1-4 clade into activators and repressors. By valine substitution in the 9aaTADs, Sp1 and Sp3 regained their original activator function found in ancestral lower metazoan sea sponges. Therefore, the vertebrate SP1-4 clade could include both repressors and activators. Furthermore, we identified secondary 9aaTADs in Sp2 introns present from fish to primates, including humans. In the gibbon genome, introns containing 9aaTADs were used as exons, which turned the Sp2 gene into an activator. Similarly, we identified introns containing 9aaTADs used conditionally as exons in the (SP family-unrelated) transcription factor SREBP1, suggesting that the intron-9aaTAD reservoir is a general phenomenon.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023049
- 003
- CZ-PrNML
- 005
- 20201214125207.0
- 007
- ta
- 008
- 201125s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00018-019-03251-w $2 doi
- 035 __
- $a (PubMed)31375868
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Piskacek, Martin $u Department of Pathological Physiology, Faculty of Medicine, Laboratory of Cancer Biology and Genetics, Masaryk University Brno, Kamenice 5, Brno, 625 00, Czech Republic. Piskacek@med.muni.cz.
- 245 14
- $a The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs / $c M. Piskacek, M. Havelka, K. Jendruchova, A. Knight, LP. Keegan,
- 520 9_
- $a The universal nine-amino-acid transactivation domains (9aaTADs) have been identified in numerous transcription activators. Here, we identified the conserved 9aaTAD motif in all nine members of the specificity protein (SP) family. Previously, the Sp1 transcription factor has been defined as a glutamine-rich activator. We showed by amino acid substitutions that the glutamine residues are completely dispensable for 9aaTAD function and are not conserved in the SP family. We described the origin and evolutionary history of 9aaTADs. The 9aaTADs of the ancestral Sp2 gene became inactivated in early chordates. We next discovered that an accumulation of valines in 9aaTADs inactivated their transactivation function and enabled their strict conservation during evolution. Subsequently, in chordates, Sp2 has duplicated and created new paralogs, Sp1, Sp3, and Sp4 (the SP1-4 clade). During chordate evolution, the dormancy of the Sp2 activation domain lasted over 100 million years. The dormant but still intact ancestral Sp2 activation domains allowed diversification of the SP1-4 clade into activators and repressors. By valine substitution in the 9aaTADs, Sp1 and Sp3 regained their original activator function found in ancestral lower metazoan sea sponges. Therefore, the vertebrate SP1-4 clade could include both repressors and activators. Furthermore, we identified secondary 9aaTADs in Sp2 introns present from fish to primates, including humans. In the gibbon genome, introns containing 9aaTADs were used as exons, which turned the Sp2 gene into an activator. Similarly, we identified introns containing 9aaTADs used conditionally as exons in the (SP family-unrelated) transcription factor SREBP1, suggesting that the intron-9aaTAD reservoir is a general phenomenon.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a molekulární evoluce $7 D019143
- 650 _2
- $a duplikace genu $7 D020440
- 650 12
- $a regulace genové exprese $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a introny $x genetika $7 D007438
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a sekvenční homologie $7 D017385
- 650 _2
- $a transkripční faktor Sp2 $x antagonisté a inhibitory $x genetika $x metabolismus $7 D051704
- 650 _2
- $a aktivace transkripce $7 D015533
- 650 _2
- $a valin $x genetika $x metabolismus $7 D014633
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Havelka, Marek $u Department of Pathological Physiology, Faculty of Medicine, Laboratory of Cancer Biology and Genetics, Masaryk University Brno, Kamenice 5, Brno, 625 00, Czech Republic.
- 700 1_
- $a Jendruchova, Kristina $u Department of Pathological Physiology, Faculty of Medicine, Laboratory of Cancer Biology and Genetics, Masaryk University Brno, Kamenice 5, Brno, 625 00, Czech Republic.
- 700 1_
- $a Knight, Andrea $u Department of Pathological Physiology, Faculty of Medicine, Gamma Delta T Cell Laboratory, Masaryk University Brno, Kamenice 5, Brno, 625 00, Czech Republic. knight@med.muni.cz.
- 700 1_
- $a Keegan, Liam P $u CEITEC, Masaryk University, Kamenice 753/5, Pavilion A35, Brno, 62 500, Czech Republic. liam.keegan@ceitec.muni.cz.
- 773 0_
- $w MED00001078 $t Cellular and molecular life sciences : CMLS $x 1420-9071 $g Roč. 77, č. 9 (2020), s. 1793-1810
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31375868 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125207 $b ABA008
- 999 __
- $a ok $b bmc $g 1595368 $s 1113725
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 77 $c 9 $d 1793-1810 $e 20190802 $i 1420-9071 $m Cellular and molecular life sciences $n Cell Mol Life Sci $x MED00001078
- GRA __
- $a 15-32935A $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $a Pubmed-20201125